Tag: Skin Disorders: Misc.
Debt Valuation of Private Equity-Backed Dermatology Groups Down
Valuation of debt instruments significantly decreased from May to August 2019, followed by further decrease during COVID-19
Spironolactone Use Not Linked to Increased Risk for Cancer
No significant associations seen for spironolactone with risk for breast, ovarian, bladder, kidney, gastric, esophageal cancers
Novel Algorithm May Help Classify Skin Diseases
New algorithm uses multistage fusion process that includes clinical images, dermoscopy images, and patient meta-data
COVID-19 Proning Teams Benefit From Wound Care Specialist Nurse
Findings show inclusion significantly cuts odds of pressure injuries in patients hospitalized with severe COVID-19
Depression Up in Pediatric, Adult Hidradenitis Suppurativa Patients
Prevalence of depression increased among adults and children with hidradenitis suppurativa
Antibiotic Choices for Skin, Soft Tissue Infections Vary by Race
Compared with White inpatients, Black inpatients less likely to receive cefazolin, more likely to receive clindamycin for SSTIs
COVID-19 Severity Does Not Differ for Patients With Skin Conditions
Acute COVID-19 and its treatment can impact the course of skin disease in vitiligo, psoriasis, atopic dermatitis, chronic urticaria
Oral Nadolol Feasible for the Treatment of Infantile Hemangiomas
Randomized clinical trial shows oral nadolol noninferior to oral propranolol for treatment of infantile hemangiomas
Adalimumab Efficacious Adjunct to Surgery for Hidradenitis Suppurativa
Risk for postoperative wound infection, complications, hemorrhage no greater with adalimumab versus placebo in hidradenitis suppurativa
